| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.8 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.037 | 0.8 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.038 | 0.8 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |